Navigating regulatory challenges in molecularly tailored nanomedicine
![Thumbnail](/bitstream/handle/10576/54982/10139.pdf.jpg?sequence=5&isAllowed=y)
عرض / فتح
التاريخ
2024-04-25المؤلف
Singh, Ajay VikramBhardwaj, Preeti
Upadhyay, Aditya Kumar
Pagani, Anselmo
Upadhyay, Jyoti
Bhadra, Jolly
Tisato, Veronica
Thakur, Manali
Gemmati, Donato
Mishra, Rudresh
Zamboni, Paolo
...show more authors ...show less authors
البيانات الوصفية
عرض كامل للتسجيلةالملخص
Nanomedicine, a convergence of nanotechnology and medical sciences, has unleashed transformative potential in healthcare. However, harnessing the benefits of nanomedicine requires a thorough understanding of its regulatory landscape. An in-depth discussion of regulatory considerations, including molecular safety assessment, harmonization of the regulatory landscape, and shaping the future of innovation, is presented in this discourse. The molecular safety assessment entails evaluating interactions between nanoparticles and biomolecules, ensuring compatibility at the molecular level. Harmonization involves developing international standards and guidelines for a consistent regulatory approach, while shaping innovations emphasizes integrating molecular safety assessments into early stages of development. Challenges encompass the need for standardized assessment methods, balancing innovation with safety, and addressing unique features of novel molecular designs. As the nanomedicine landscape evolves, effective regulatory strategies must navigate the intricate interplay of molecules and technologies, ensuring both patient access and product safety.
المجموعات
- أبحاث مركز جامعة قطر للعلماء الشباب [202 items ]